메뉴 건너뛰기




Volumn 10, Issue 26, 2004, Pages 3297-3312

Adjunctive immunotherapy of mycobacterial infections

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; AZITHROMYCIN; BCG VACCINE; BENZOPYRAN DERIVATIVE; CORTICOSTEROID DERIVATIVE; DECORIN; DIETHYLDITHIOCARBAMIC ACID; DNA VACCINE; ETANERCEPT; GALACTOSYLCERAMIDE; IMIDAZOQUINOLINE DERIVATIVE; INFLIXIMAB; INTERLEUKIN 10 ANTIBODY; ISONIAZID; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGODEOXYNUCLEOTIDE DERIVATIVE; ONERCEPT; POLOXAMER; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 18; RECOMBINANT INTERLEUKIN 2; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

EID: 4644221287     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043383232     Document Type: Review
Times cited : (50)

References (110)
  • 1
    • 0027310892 scopus 로고
    • Treatment and prevention of multidrug-resistant tuberculosis
    • Cohn DL, Iseman MD. Treatment and prevention of multidrug-resistant tuberculosis. Res Microbiol 1993; 144: 150-3.
    • (1993) Res. Microbiol. , vol.144 , pp. 150-153
    • Cohn, D.L.1    Iseman, M.D.2
  • 2
    • 0034012047 scopus 로고    scopus 로고
    • Prospects for development of new antimycobacterial drugs
    • Tomioka H. Prospects for development of new antimycobacterial drugs. J Infect Chemother 2000; 6: 8-20.
    • (2000) J. Infect. Chemother. , vol.6 , pp. 8-20
    • Tomioka, H.1
  • 4
    • 0030626890 scopus 로고    scopus 로고
    • Disseminated Mycobacterium avium complex infection: Implications of recent clinical trials on prophylaxis and treatment
    • Benson CA. Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment. AIDS Clin Rev 1997; 98: 271-87.
    • (1997) AIDS Clin. Rev. , vol.98 , pp. 271-287
    • Benson, C.A.1
  • 5
    • 0037324356 scopus 로고    scopus 로고
    • Type II pneumocytes in the evaluation of drug antimycobacterial activity
    • Tomioka H. Type II pneumocytes in the evaluation of drug antimycobacterial activity. Exp Opin Pharmacother 2003; 4: 127-39.
    • (2003) Exp. Opin. Pharmacother. , vol.4 , pp. 127-139
    • Tomioka, H.1
  • 6
    • 4644255288 scopus 로고    scopus 로고
    • Immune response in the hosts with mycobacterial infection
    • Tomioka H. Immune response in the hosts with mycobacterial infection. Clin Microbiol (Tokyo) 1997; 24: 45-52.
    • (1997) Clin. Microbiol. (Tokyo) , vol.24 , pp. 45-52
    • Tomioka, H.1
  • 8
    • 0346784887 scopus 로고    scopus 로고
    • Profiles of cytokine network in the hosts with mycobacterial infection
    • Tormoka H. Profiles of cytokine network in the hosts with mycobacterial infection. Clin Immunol (Tokyo) 2001; 35: 571-9.
    • (2001) Clin. Immunol. (Tokyo) , vol.35 , pp. 571-579
    • Tormoka, H.1
  • 9
    • 0032934002 scopus 로고    scopus 로고
    • The taming of IL-12: Suppressing the production of proinflammatory cytokines
    • Sutterwala FS, Mosser DM. The taming of IL-12: suppressing the production of proinflammatory cytokines. J Leukoc Biol 1999; 65: 543-51.
    • (1999) J. Leukoc. Biol. , vol.65 , pp. 543-551
    • Sutterwala, F.S.1    Mosser, D.M.2
  • 11
    • 0034500805 scopus 로고    scopus 로고
    • Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion
    • Dupuis S, Doffinger R, Picard C, et al. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178: 129-37.
    • (2000) Immunol. Rev. , vol.178 , pp. 129-137
    • Dupuis, S.1    Doffinger, R.2    Picard, C.3
  • 12
    • 0033559125 scopus 로고    scopus 로고
    • Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for lymphotoxin
    • Bean AG, Roach DR, Briscoe H, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for lymphotoxin. J Immunol 1999; 162: 3504-11.
    • (1999) J. Immunol. , vol.162 , pp. 3504-3511
    • Bean, A.G.1    Roach, D.R.2    Briscoe, H.3
  • 13
    • 0034035311 scopus 로고    scopus 로고
    • Interleukin-6 induced early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection
    • Saunders BM, Frank AA, Orme IM, Cooper AM. Interleukin-6 induced early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000; 68: 3322-6.
    • (2000) Infect. Immun. , vol.68 , pp. 3322-3326
    • Saunders, B.M.1    Frank, A.A.2    Orme, I.M.3    Cooper, A.M.4
  • 14
    • 0033618562 scopus 로고    scopus 로고
    • Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors
    • Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999; 285: 732-6.
    • (1999) Science , vol.285 , pp. 732-736
    • Brightbill, H.D.1    Libraty, D.H.2    Krutzik, S.R.3
  • 15
    • 0030790652 scopus 로고    scopus 로고
    • Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
    • Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186: 39-45.
    • (1997) J. Exp. Med. , vol.186 , pp. 39-45
    • Cooper, A.M.1    Magram, J.2    Ferrante, J.3    Orme, I.M.4
  • 16
    • 18244428735 scopus 로고    scopus 로고
    • Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
    • Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-5.
    • (1998) Science , vol.280 , pp. 1432-1435
    • Altare, F.1    Durandy, A.2    Lammas, D.3
  • 17
    • 0032037616 scopus 로고    scopus 로고
    • Macrophage receptors for Mycobacterium tuberculosis
    • Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998; 66: 1277-81.
    • (1998) Infect. Immun. , vol.66 , pp. 1277-1281
    • Ernst, J.D.1
  • 18
    • 0034307339 scopus 로고    scopus 로고
    • The Toll receptor family and microbial recognition
    • Medzhitov R, Janeway C Jr. The Toll receptor family and microbial recognition. Trends Microbiol 2000; 8: 452-6.
    • (2000) Trends Microbiol. , vol.8 , pp. 452-456
    • Medzhitov, R.1    Janeway Jr., C.2
  • 19
    • 0034283670 scopus 로고    scopus 로고
    • Mycobacterium tuberculosis infection in complement receptor 3-deficient mice
    • Hu C, Mayadas-Norton T, Tanaka K, Chan J, Salgame P. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J Immunol 2000; 165: 2596-602.
    • (2000) J. Immunol. , vol.165 , pp. 2596-2602
    • Hu, C.1    Mayadas-Norton, T.2    Tanaka, K.3    Chan, J.4    Salgame, P.5
  • 20
    • 0036120669 scopus 로고    scopus 로고
    • Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens
    • Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002; 80: 147-62.
    • (2002) J. Mol. Med. , vol.80 , pp. 147-162
    • Biet, F.1    Locht, C.2    Kremer, L.3
  • 21
    • 0032924518 scopus 로고    scopus 로고
    • Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice
    • Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 1999; 67: 2585-9.
    • (1999) Infect. Immun. , vol.67 , pp. 2585-2589
    • Sugawara, I.1    Yamada, H.2    Kaneko, H.3    Mizuno, S.4    Takeda, K.5    Akira, S.6
  • 22
    • 0034114110 scopus 로고    scopus 로고
    • Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice
    • Maeurer MJ, Trinder P, Hommel G, et al. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun 2000; 68: 2962-70.
    • (2000) Infect. Immun. , vol.68 , pp. 2962-2970
    • Maeurer, M.J.1    Trinder, P.2    Hommel, G.3
  • 23
    • 0033823682 scopus 로고    scopus 로고
    • Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis
    • Juffermans NP, Florquin S, Camoglio L, et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000; 182: 902-8.
    • (2000) J. Infect. Dis. , vol.182 , pp. 902-908
    • Juffermans, N.P.1    Florquin, S.2    Camoglio, L.3
  • 24
    • 0031252325 scopus 로고    scopus 로고
    • Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice: Analysis of local and regional cytokine and chemokine networks
    • Chensue SW, Warmington K, Ruth JH, Lukacs N, Kunkel SL. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 1997; 159: 3565-73.
    • (1997) J. Immunol. , vol.159 , pp. 3565-3573
    • Chensue, S.W.1    Warmington, K.2    Ruth, J.H.3    Lukacs, N.4    Kunkel, S.L.5
  • 25
    • 0033048886 scopus 로고    scopus 로고
    • Increased antimycobacterial immunity in interleukin-10-deficient mice
    • Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999; 67: 3087-95.
    • (1999) Infect. Immun. , vol.67 , pp. 3087-3095
    • Murray, P.J.1    Young, R.A.2
  • 26
    • 0037237593 scopus 로고    scopus 로고
    • Mycobacteria target DC-SIGN to suppress dendritic cell function
    • Geijtenbeek TBH, van Vliet SJ, Koppel EA, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197: 7-17.
    • (2003) J. Exp. Med. , vol.197 , pp. 7-17
    • Geijtenbeek, T.B.H.1    van Vliet, S.J.2    Koppel, E.A.3
  • 27
    • 0029952226 scopus 로고    scopus 로고
    • Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse
    • Vodovotz Y, Geiser AG, Chesler L, et al. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse. J Exp Med 1996; 183: 2337-42.
    • (1996) J. Exp. Med. , vol.183 , pp. 2337-2342
    • Vodovotz, Y.1    Geiser, A.G.2    Chesler, L.3
  • 28
    • 0032994332 scopus 로고    scopus 로고
    • The modulating effects of proinflammatory cytokines interferon-gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-β), on antimicrobial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex
    • Sano C, Sato K, Tomioka H, et al. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-β), on antimicrobial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex. Clin Exp Immunol 1999; 115: 435-42.
    • (1999) Clin. Exp. Immunol. , vol.115 , pp. 435-442
    • Sano, C.1    Sato, K.2    Tomioka, H.3
  • 29
    • 0032212187 scopus 로고    scopus 로고
    • IL-4 in combination with TGF-βfavors an alternative pathway of Th1 development independent of IL-12
    • Lingnau K, Hoehn P, Kerdine S, et al. IL-4 in combination with TGF-βfavors an alternative pathway of Th1 development independent of IL-12. J Immunol 1998; 161: 4709-18.
    • (1998) J. Immunol. , vol.161 , pp. 4709-4718
    • Lingnau, K.1    Hoehn, P.2    Kerdine, S.3
  • 30
    • 0028028416 scopus 로고
    • Interferon-gamma and host antimicrobial defense: Current and future clinical applications
    • Murray HW. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am J Med 1994; 97: 459-67.
    • (1994) Am. J. Med. , vol.97 , pp. 459-467
    • Murray, H.W.1
  • 31
    • 0028830865 scopus 로고
    • Recombinant cytokines for controlling mycobacterial infections
    • Bermudez LE, Kaplan G. Recombinant cytokines for controlling mycobacterial infections. Trend Microbiol 1995; 3: 22-7.
    • (1995) Trend Microbiol. , vol.3 , pp. 22-27
    • Bermudez, L.E.1    Kaplan, G.2
  • 32
    • 0031819715 scopus 로고    scopus 로고
    • Adjunctive immunotherapy of tuberculosis
    • Toossi Z. Adjunctive immunotherapy of tuberculosis. Cytokine Cell Mol Ther 1998; 4: 105-12.
    • (1998) Cytokine Cell Mol. Ther. , vol.4 , pp. 105-112
    • Toossi, Z.1
  • 33
    • 0033630312 scopus 로고    scopus 로고
    • Cytokine therapy of mycobacterial infections
    • Holland SM. Cytokine therapy of mycobacterial infections. Adv Intern Med 2000; 45: 431-52.
    • (2000) Adv. Intern. Med. , vol.45 , pp. 431-452
    • Holland, S.M.1
  • 34
    • 0029744248 scopus 로고    scopus 로고
    • Use of adjunctive treatment with interferon-γ in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain
    • Raad I, Hachem R, Leeds N, Sawaya R, Salem Z, Atweb S. Use of adjunctive treatment with interferon-γ in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain. Clin Infect Dis 1996; 22: 572-4.
    • (1996) Clin. Infect. Dis. , vol.22 , pp. 572-574
    • Raad, I.1    Hachem, R.2    Leeds, N.3    Sawaya, R.4    Salem, Z.5    Atweb, S.6
  • 35
    • 0026768363 scopus 로고
    • Interferon-gamma treatment for Mycobacterium avium-intracellulare complex bacillemia in patients with AIDS
    • Squires KE, Brown ST, Armstrong D, Murphy WF, Murray HW. Interferon-gamma treatment for Mycobacterium avium-intracellulare complex bacillemia in patients with AIDS. J Infect Dis 1992; 166: 686-7.
    • (1992) J. Infect. Dis. , vol.166 , pp. 686-687
    • Squires, K.E.1    Brown, S.T.2    Armstrong, D.3    Murphy, W.F.4    Murray, H.W.5
  • 36
    • 0028281757 scopus 로고
    • Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: A preliminary report
    • Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: A preliminary report. N Engl J Med 1994; 330: 1348-55.
    • (1994) N. Engl. J. Med. , vol.330 , pp. 1348-1355
    • Holland, S.M.1    Eisenstein, E.M.2    Kuhns, D.B.3
  • 37
    • 0030961425 scopus 로고    scopus 로고
    • Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol
    • Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997; 349: 1513-5.
    • (1997) Lancet , vol.349 , pp. 1513-1515
    • Condos, R.1    Rom, W.N.2    Schluger, N.W.3
  • 38
    • 0032248830 scopus 로고    scopus 로고
    • Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis
    • Johnson B, Bekker LG, Ress S, Kaplan G. Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis. Novartis Found Symp 1998; 217: 99-106.
    • (1998) Novartis Found. Symp. , vol.217 , pp. 99-106
    • Johnson, B.1    Bekker, L.G.2    Ress, S.3    Kaplan, G.4
  • 39
    • 0042532279 scopus 로고    scopus 로고
    • Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis
    • Johnson JL, Ssekasanvu E, Okwera A, et al. Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 168: 185-91.
    • (2003) Am. J. Respir. Crit. Care Med. , vol.168 , pp. 185-191
    • Johnson, J.L.1    Ssekasanvu, E.2    Okwera, A.3
  • 40
    • 0027954447 scopus 로고
    • Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model
    • Bermudez LE, Martinelli J, Petrofsky M, Kolonoski P, Young LS. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. J Infect Dis 1994; 169: 575-80.
    • (1994) J. Infect. Dis. , vol.169 , pp. 575-580
    • Bermudez, L.E.1    Martinelli, J.2    Petrofsky, M.3    Kolonoski, P.4    Young, L.S.5
  • 41
    • 0031969767 scopus 로고    scopus 로고
    • Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor
    • Kemper CA, Bermudez LE, Deresinski SC. Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. J Infect Dis 1998; 177: 914-20.
    • (1998) J. Infect. Dis. , vol.177 , pp. 914-920
    • Kemper, C.A.1    Bermudez, L.E.2    Deresinski, S.C.3
  • 42
    • 0028686379 scopus 로고
    • Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF
    • Bermudez LE, Kemper CA, Deresinski SC. Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF. Biotherapy 1994; 8: 135-42.
    • (1994) Biotherapy , vol.8 , pp. 135-142
    • Bermudez, L.E.1    Kemper, C.A.2    Deresinski, S.C.3
  • 43
    • 0034011843 scopus 로고    scopus 로고
    • Isolated cutaneous response to granulocyte-monocyte colony stimulating factor in fatal idiopathic disseminated Bacillus-Calmette-Guérin infection
    • Sanal O, Morgan G, Gocmen A, et al. Isolated cutaneous response to granulocyte-monocyte colony stimulating factor in fatal idiopathic disseminated Bacillus-Calmette-Guérin infection. Eur J Pediatr 2000; 159: 149-52.
    • (2000) Eur. J. Pediatr. , vol.159 , pp. 149-152
    • Sanal, O.1    Morgan, G.2    Gocmen, A.3
  • 44
    • 0028135425 scopus 로고
    • T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection
    • Zhang M, Gong J, Iyer D, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94: 2435-42.
    • (1994) J. Clin. Invest. , vol.94 , pp. 2435-2442
    • Zhang, M.1    Gong, J.2    Iyer, D.3    Jones, B.E.4    Modlin, R.L.5    Barnes, P.F.6
  • 45
    • 15144345622 scopus 로고    scopus 로고
    • IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice
    • Doherty TM, Sher A. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J Immunol 1998; 160: 5428-35.
    • (1998) J. Immunol. , vol.160 , pp. 5428-5435
    • Doherty, T.M.1    Sher, A.2
  • 46
    • 4243726293 scopus 로고    scopus 로고
    • Interleukin-12 (IL-12) treatment in interferon gamma refractory pulmonary M.abscessus infection: Clinical response and immunologic reconstitution
    • Holland SM, Dorman SE. Interleukin-12 (IL-12) treatment in interferon gamma refractory pulmonary M.abscessus infection: Clinical response and immunologic reconstitution. J Invest Med 1998; 46(suppl): 218A.
    • (1998) J. Invest. Med. , vol.46 , Issue.SUPPL.
    • Holland, S.M.1    Dorman, S.E.2
  • 47
    • 0031657190 scopus 로고    scopus 로고
    • Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice
    • Bermudez LE, Petrofsky M, Wu M, Young LS. Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice. J Infect Dis 1998; 178: 896-9.
    • (1998) J. Infect. Dis. , vol.178 , pp. 896-899
    • Bermudez, L.E.1    Petrofsky, M.2    Wu, M.3    Young, L.S.4
  • 48
    • 0025353729 scopus 로고
    • Negative regulation of transforming growth factor-β by the proteoglycan decorin
    • Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990; 346: 281-4.
    • (1990) Nature , vol.346 , pp. 281-284
    • Yamaguchi, Y.1    Mann, D.M.2    Ruoslahti, E.3
  • 49
    • 0029897379 scopus 로고    scopus 로고
    • The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice
    • Bottinger EP, Factor VM, Tsang ML, et al. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 5877-82.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 5877-5882
    • Bottinger, E.P.1    Factor, V.M.2    Tsang, M.L.3
  • 50
    • 0035424768 scopus 로고    scopus 로고
    • Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination
    • Silva RA, Pais TF, Appleberg R. Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J Immunol 2001; 167: 1535-41.
    • (2001) J. Immunol. , vol.167 , pp. 1535-1541
    • Silva, R.A.1    Pais, T.F.2    Appleberg, R.3
  • 51
    • 0032927190 scopus 로고    scopus 로고
    • Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection
    • Shimizu T, Tomioka H, Sato K, et al. Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection. Int J Antimicrob Agents 1999; 11: 69-74.
    • (1999) Int. J. Antimicrob. Agents , vol.11 , pp. 69-74
    • Shimizu, T.1    Tomioka, H.2    Sato, K.3
  • 52
    • 0027462029 scopus 로고
    • Corticosteroids and tuberculosis: Risks and use as adjunctive therapy
    • Alzeer AH, FitzGerald JM. Corticosteroids and tuberculosis: risks and use as adjunctive therapy. Tuberc Lung Dis 1993; 74: 6-11.
    • (1993) Tuberc. Lung Dis. , vol.74 , pp. 6-11
    • Alzeer, A.H.1    FitzGerald, J.M.2
  • 53
    • 0029052040 scopus 로고
    • Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature
    • Muthuswamy P, Hu T-C, Carasso B, Antonio M, Dandamudi N. Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature. Chest 1995; 107: 1621-30.
    • (1995) Chest , vol.107 , pp. 1621-1630
    • Muthuswamy, P.1    Hu, T.-C.2    Carasso, B.3    Antonio, M.4    Dandamudi, N.5
  • 54
    • 0030861680 scopus 로고    scopus 로고
    • Adjunctive corticosteroid therapy for tuberculosis: A critical reappraisal of the literature
    • Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997; 25: 872-87.
    • (1997) Clin. Infect. Dis. , vol.25 , pp. 872-887
    • Dooley, D.P.1    Carpenter, J.L.2    Rademacher, S.3
  • 55
    • 0031969210 scopus 로고    scopus 로고
    • Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed
    • Dorman SE, Heller HM, Basgoz NO, Sax PE. Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed. Clin Infect Dis 1998; 26: 682-6.
    • (1998) Clin. Infect. Dis. , vol.26 , pp. 682-686
    • Dorman, S.E.1    Heller, H.M.2    Basgoz, N.O.3    Sax, P.E.4
  • 58
    • 0029295913 scopus 로고
    • Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis
    • Tramontana JM, Utaipat U, Molloy A, et al. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995; 1: 384-97.
    • (1995) Mol. Med. , vol.1 , pp. 384-397
    • Tramontana, J.M.1    Utaipat, U.2    Molloy, A.3
  • 59
    • 0033840044 scopus 로고    scopus 로고
    • Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role
    • Schoeman JF, Springer P, Ravenscroft A, et al. Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. J Child Neurol 2000; 15: 497-503.
    • (2000) J. Child. Neurol. , vol.15 , pp. 497-503
    • Schoeman, J.F.1    Springer, P.2    Ravenscroft, A.3
  • 60
    • 0142072978 scopus 로고    scopus 로고
    • TNF-α as therapeutic target: New drugs, more applications
    • Reimold AM. TNF-α as therapeutic target: new drugs, more applications. Curr Drug Targets Inflamm Allergy 2002; 1: 377-92.
    • (2002) Curr. Drug Targets Inflamm. Allergy , vol.1 , pp. 377-392
    • Reimold, A.M.1
  • 61
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
    • Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098-104.
    • (2001) N. Engl. J. Med. , vol.345 , pp. 1098-1104
    • Keane, J.1    Gershon, S.2    Wise, R.P.3
  • 63
    • 0038076340 scopus 로고    scopus 로고
    • Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection
    • Long R, Gardam M. Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection. CMAJ 2003; 168: 1153-6.
    • (2003) CMAJ , vol.168 , pp. 1153-1156
    • Long, R.1    Gardam, M.2
  • 65
    • 4644329432 scopus 로고    scopus 로고
    • ATP-mediated potentiation of antimicrobial activity of macrophages
    • Tomioka H. ATP-mediated potentiation of antimicrobial activity of macrophages. Clin Immunol (Tokyo) 2003; 40: 442-9.
    • (2003) Clin. Immunol. (Tokyo) , vol.40 , pp. 442-449
    • Tomioka, H.1
  • 66
    • 0033966376 scopus 로고    scopus 로고
    • Macrophage control of mycobacterial growth induced by picolinic acid is dependent on host cell apoptosis
    • Pais TF, Appelberg R. Macrophage control of mycobacterial growth induced by picolinic acid is dependent on host cell apoptosis. J Immunol 2000; 164: 389-97.
    • (2000) J. Immunol. , vol.164 , pp. 389-397
    • Pais, T.F.1    Appelberg, R.2
  • 67
    • 0034769807 scopus 로고    scopus 로고
    • Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele)
    • Moisan J, Wojciechowski W, Guilbault C, et al. Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele). Antimicrob Agents Chemother 2001; 45: 3059-64.
    • (2001) Antimicrob Agents Chemother. , vol.45 , pp. 3059-3064
    • Moisan, J.1    Wojciechowski, W.2    Guilbault, C.3
  • 68
  • 69
    • 0034691583 scopus 로고    scopus 로고
    • Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages
    • Jagannath C, Sepulveda E, Actor JK, Luxem F, Emanuele MR, Hunter RL. Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages. Immunopharmacology 2000; 48: 185-97.
    • (2000) Immunopharmacology , vol.48 , pp. 185-197
    • Jagannath, C.1    Sepulveda, E.2    Actor, J.K.3    Luxem, F.4    Emanuele, M.R.5    Hunter, R.L.6
  • 70
    • 0024412053 scopus 로고
    • Activity of FCE 20696, a new synthetic immunomodulator, in models of viral and bacterial pathology
    • Verini MA, Ungheri D. Activity of FCE 20696, a new synthetic immunomodulator, in models of viral and bacterial pathology. Immunopharmacology 1989; 17: 157-65.
    • (1989) Immunopharmacology , vol.17 , pp. 157-165
    • Verini, M.A.1    Ungheri, D.2
  • 71
    • 0036839648 scopus 로고    scopus 로고
    • Activation of NKT cells protects mice from tuberculosis
    • Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002; 70: 6302-9.
    • (2002) Infect. Immun. , vol.70 , pp. 6302-6309
    • Chackerian, A.1    Alt, J.2    Perera, V.3    Behar, S.M.4
  • 72
    • 0037443555 scopus 로고    scopus 로고
    • Human NKT cells express granulysin and exhibit antimycobacterial activity
    • Gansert JL, Kiessler V, Engele M, et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003; 170: 3154-61.
    • (2003) J. Immunol. , vol.170 , pp. 3154-3161
    • Gansert, J.L.1    Kiessler, V.2    Engele, M.3
  • 73
    • 0032993028 scopus 로고    scopus 로고
    • Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice
    • Sano C, Shimizu T, Sato K, Kawauchi H, Kawahara S, Tomioka H. Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice. Antimicrob Agents Chemother 1999; 43: 360-4.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 360-364
    • Sano, C.1    Shimizu, T.2    Sato, K.3    Kawauchi, H.4    Kawahara, S.5    Tomioka, H.6
  • 74
    • 0032979371 scopus 로고    scopus 로고
    • Effects of the Chinese traditional medicine Mao-Bushi-Saishin-To on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice
    • Shimizu T, Tomioka H, Sato K, et al. Effects of the Chinese traditional medicine Mao-Bushi-Saishin-To on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice. Antimicrob Agents Chemother 1999; 43: 514-9.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 514-519
    • Shimizu, T.1    Tomioka, H.2    Sato, K.3
  • 75
    • 0028225787 scopus 로고
    • Levamisole as an immunopotentiator for T cell deficiency
    • Taki HN, Schwartz SA. Levamisole as an immunopotentiator for T cell deficiency. Immunopharmacol Immunotoxicol 1994; 16: 129-37.
    • (1994) Immunopharmacol. Immunotoxicol. , vol.16 , pp. 129-137
    • Taki, H.N.1    Schwartz, S.A.2
  • 76
    • 0025753722 scopus 로고
    • Killing of Mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol
    • Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991; 84: 200-6.
    • (1991) Clin. Exp. Immunol. , vol.84 , pp. 200-206
    • Denis, M.1
  • 77
    • 0023022324 scopus 로고
    • Triton WR-1339 as a biological response modifier in mycobacterial infection
    • Kondo E, Kanai K. Triton WR-1339 as a biological response modifier in mycobacterial infection. Jpn J Med Sci Biol 1986; 39: 35-47.
    • (1986) Jpn. J. Med. Sci. Biol. , vol.39 , pp. 35-47
    • Kondo, E.1    Kanai, K.2
  • 78
    • 0030851549 scopus 로고    scopus 로고
    • The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculosis infection and in vitro superoxide anion production
    • Venkataprasad N, Ledger P, Ivanyi J. The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculosis infection and in vitro superoxide anion production. Int Arch Allergy Immunol 1997; 114: 23-9.
    • (1997) Int. Arch. Allergy Immunol. , vol.114 , pp. 23-29
    • Venkataprasad, N.1    Ledger, P.2    Ivanyi, J.3
  • 79
    • 0034832968 scopus 로고    scopus 로고
    • Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2, 3-dioxygenase
    • Hayashi T, Rao SP, Takabayashi K. et al. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2, 3-dioxygenase. Infect Immun 2001; 69: 6156-64.
    • (2001) Infect. Immun. , vol.69 , pp. 6156-6164
    • Hayashi, T.1    Rao, S.P.2    Takabayashi, K.3
  • 80
    • 0033566165 scopus 로고    scopus 로고
    • Therapy of tuberculosis in mice by DNA vaccination
    • Lowrie DB, Tascon RE, Bonato VL, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269-71.
    • (1999) Nature , vol.400 , pp. 269-271
    • Lowrie, D.B.1    Tascon, R.E.2    Bonato, V.L.3
  • 81
    • 0030034978 scopus 로고    scopus 로고
    • Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines
    • Murray PJ, Aldovini A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 1996; 93: 934-9.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 934-939
    • Murray, P.J.1    Aldovini, A.2    Young, R.A.3
  • 82
    • 0027971335 scopus 로고
    • Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659
    • Stanford JL, Stanford CA. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659. Immunobiology 1994; 191: 555-63.
    • (1994) Immunobiology , vol.191 , pp. 555-563
    • Stanford, J.L.1    Stanford, C.A.2
  • 83
    • 0034066912 scopus 로고    scopus 로고
    • Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis
    • The Uganda-Case Western Reserve University Research Collaboration
    • Johnson JL, Kamya RM, Okwera A, et al. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration. J Infect Dis 2000; 181: 1304-12.
    • (2000) J. Infect. Dis. , vol.181 , pp. 1304-1312
    • Johnson, J.L.1    Kamya, R.M.2    Okwera, A.3
  • 84
    • 0031770379 scopus 로고    scopus 로고
    • Purinergic signalling: Pathophysiological roles
    • Abbracchio MP, Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 1998; 78: 113-45.
    • (1998) Jpn. J. Pharmacol. , vol.78 , pp. 113-145
    • Abbracchio, M.P.1    Burnstock, G.2
  • 89
    • 0033957426 scopus 로고    scopus 로고
    • ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D
    • Kusner DJ, Adams J. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol 2000; 164: 379-88.
    • (2000) J. Immunol. , vol.164 , pp. 379-388
    • Kusner, D.J.1    Adams, J.2
  • 90
    • 0035873728 scopus 로고    scopus 로고
    • ATP-mediated killing of Mycobacterium bovis Bacille Calmette-Guérin within human macrophage is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes
    • Stober CB, Lammas DA, Li CM, Kumararatne DS, Lightman SL, McArdle CA. ATP-mediated killing of Mycobacterium bovis Bacille Calmette-Guérin within human macrophage is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J Immunol 2001; 166: 6276-86.
    • (2001) J. Immunol. , vol.166 , pp. 6276-6286
    • Stober, C.B.1    Lammas, D.A.2    Li, C.M.3    Kumararatne, D.S.4    Lightman, S.L.5    McArdle, C.A.6
  • 91
    • 0035884993 scopus 로고    scopus 로고
    • ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion
    • Kusner DJ, Barton JA. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol 2001; 167: 3308-15.
    • (2001) J. Immunol. , vol.167 , pp. 3308-3315
    • Kusner, D.J.1    Barton, J.A.2
  • 92
    • 0036969879 scopus 로고    scopus 로고
    • Effects of ATP on the in vitro and in vivo antimicrobial activity of murine macrophages against Mycobacterium avium complex
    • Sano C, Sano K, Sato K, Ogasawara K, Shimizu T, Tomioka H. Effects of ATP on the in vitro and in vivo antimicrobial activity of murine macrophages against Mycobacterium avium complex. Jpn J Chemother 2002; 50: 848-53.
    • (2002) Jpn. J. Chemother. , vol.50 , pp. 848-853
    • Sano, C.1    Sano, K.2    Sato, K.3    Ogasawara, K.4    Shimizu, T.5    Tomioka, H.6
  • 93
    • 0037293032 scopus 로고    scopus 로고
    • Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis
    • Chopra P, Singh A, Koul A, et al. Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis. Eur J Biochem 2003; 270: 625-34.
    • (2003) Eur. J. Biochem. , vol.270 , pp. 625-634
    • Chopra, P.1    Singh, A.2    Koul, A.3
  • 94
    • 0027428579 scopus 로고
    • Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans
    • Blasi E, Mazzolla R, Pitzurra L, Barluzzi R, Bistoni F. Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans. Antimicrob Agents Chemother 1993; 37: 2422-6.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 2422-2426
    • Blasi, E.1    Mazzolla, R.2    Pitzurra, L.3    Barluzzi, R.4    Bistoni, F.5
  • 95
    • 0029099053 scopus 로고
    • Cytokine induction by the immunomodulators imiquimod and S-27609
    • Testerman TL, Gerster JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365-72.
    • (1995) J. Leukoc. Biol. , vol.58 , pp. 365-372
    • Testerman, T.L.1    Gerster, J.F.2    Imbertson, L.M.3
  • 96
    • 0032795716 scopus 로고    scopus 로고
    • The activity of poloxamer CRL 1072 against Mycobacterium avium in macrophage culture and in mice
    • Jagannath C, Emanuele M, Hunter R. The activity of poloxamer CRL 1072 against Mycobacterium avium in macrophage culture and in mice. Antimicrob Agents Chemother 1999; 43: 2898-903.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 2898-2903
    • Jagannath, C.1    Emanuele, M.2    Hunter, R.3
  • 97
    • 0030696696 scopus 로고    scopus 로고
    • CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
    • Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997, 278: 1626-9.
    • (1997) Science , vol.278 , pp. 1626-1629
    • Kawano, T.1    Cui, J.2    Koezuka, Y.3
  • 98
    • 0033022704 scopus 로고    scopus 로고
    • Immunization with alpha galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
    • Burdin N, Brossay L, Kronenberg M. Immunization with alpha galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 1999; 29: 2014-25.
    • (1999) Eur. J. Immunol. , vol.29 , pp. 2014-2025
    • Burdin, N.1    Brossay, L.2    Kronenberg, M.3
  • 99
    • 0032729476 scopus 로고    scopus 로고
    • Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
    • Carnaud C, Lee D, Donnars O, et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647-50.
    • (1999) J. Immunol. , vol.163 , pp. 4647-4650
    • Carnaud, C.1    Lee, D.2    Donnars, O.3
  • 100
    • 0033526066 scopus 로고    scopus 로고
    • The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
    • Kitamura H, Iwakabe K, Yahata T, et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999; 189: 1121-8.
    • (1999) J. Exp. Med. , vol.189 , pp. 1121-1128
    • Kitamura, H.1    Iwakabe, K.2    Yahata, T.3
  • 101
    • 0021960034 scopus 로고
    • Human bronchial leukocyte protease inhibitor
    • Smith CE, Johnson DA. Human bronchial leukocyte protease inhibitor. Biochem J 1985; 225: 463-72.
    • (1985) Biochem. J. , vol.225 , pp. 463-472
    • Smith, C.E.1    Johnson, D.A.2
  • 102
    • 0026323677 scopus 로고
    • Effect of Mao-Bushi-Saishin-To on nasal allergy with nasal obstruction
    • Ito H, Baba S, Takagi I, et al. Effect of Mao-Bushi-Saishin-To on nasal allergy with nasal obstruction. Pract Otol (Tokyo) 1994: 52: 107-18.
    • (1994) Pract. Otol. (Tokyo) , vol.52 , pp. 107-118
    • Ito, H.1    Baba, S.2    Takagi, I.3
  • 103
    • 0030764558 scopus 로고    scopus 로고
    • Immunomodulatory DNA sequences function as T helper-1-promoting adjuvants
    • Roman M, Martin-Orozco E, Goodman JS, et al. Immunomodulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997; 3: 849-54.
    • (1997) Nat. Med. , vol.3 , pp. 849-854
    • Roman, M.1    Martin-Orozco, E.2    Goodman, J.S.3
  • 104
    • 0034073872 scopus 로고    scopus 로고
    • Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
    • Cho HJ, Takabayashi K, Cheng PM, et al. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol 2000; 18: 509-14.
    • (2000) Nat. Biotechnol. , vol.18 , pp. 509-514
    • Cho, H.J.1    Takabayashi, K.2    Cheng, P.M.3
  • 105
    • 0032848831 scopus 로고    scopus 로고
    • Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)
    • Dlugovitzky D, Bottasso O, Dominino JC, et al. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Repir Med 1999; 93: 557-62.
    • (1999) Repir. Med. , vol.93 , pp. 557-562
    • Dlugovitzky, D.1    Bottasso, O.2    Dominino, J.C.3
  • 106
    • 0037027056 scopus 로고    scopus 로고
    • Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: A randomized placebo-controlled trial
    • Mwinga A, Nunn A, Ngwira B, et al. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomized placebo-controlled trial. Lancet 2002; 360: 1050-5.
    • (2002) Lancet , vol.360 , pp. 1050-1055
    • Mwinga, A.1    Nunn, A.2    Ngwira, B.3
  • 107
    • 0037264496 scopus 로고    scopus 로고
    • Mycobacterium vaccae immunotherapy for treating tuberculosis
    • de Bruyn G, Garner P. Mycobacterium vaccae immunotherapy for treating tuberculosis. Cochrane Detabase Syst Rev 2003; (1): CD001166.
    • (2003) Cochrane Detabase Syst. Rev. , Issue.1
    • de Bruyn, G.1    Garner, P.2
  • 108
    • 0043180521 scopus 로고    scopus 로고
    • Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity
    • Boyaka PN, Tafaro A, Fischer R, Fujihashi K, Jirillo E, McGhee JR. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. Curr Pharm Design 2003; 9(24): 1965-72.
    • (2003) Curr. Pharm. Design , vol.9 , Issue.24 , pp. 1965-1972
    • Boyaka, P.N.1    Tafaro, A.2    Fischer, R.3    Fujihashi, K.4    Jirillo, E.5    McGhee, J.R.6
  • 109
    • 0037259397 scopus 로고    scopus 로고
    • Immune therapy for infectious diseases at the dawn of the 21st century: The past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers
    • Buchwald UK, Pirofski L. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Curr Pharm Design 2003; 9(12): 945-68.
    • (2003) Curr. Pharm. Design , vol.9 , Issue.12 , pp. 945-968
    • Buchwald, U.K.1    Pirofski, L.2
  • 110
    • 0038397268 scopus 로고    scopus 로고
    • Biodefense properties of milk: The role of antimicrobial proteins and peptides
    • Clare DA, Catignani GL, Swaisgood HE. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Design 2003; 9(16): 1239-55.
    • (2003) Curr. Pharm. Design , vol.9 , Issue.16 , pp. 1239-1255
    • Clare, D.A.1    Catignani, G.L.2    Swaisgood, H.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.